Jushi Holdings Inc. (JUSHF) Awarded Provisional Medical Marijuana Dispensary License in Ohio

Jushi Holdings Inc. Awarded Provisional Medical Marijuana Dispensary License in Ohio; Establishes…

The post Jushi Holdings Inc. (JUSHF) Awarded Provisional Medical Marijuana Dispensary License in Ohio appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
Ayr Wellness Inc. (AYRWF) Announces First Sale from 80,000 Sq. Ft. Phoenix Cultivation Facility
MariMed Inc. (MRMD) Awarded Dispensary License in Ohio

MariMed Awarded Dispensary License in Ohio MariMed Inc. (OTCQX: MRMD) (“MariMed” or…

The post MariMed Inc. (MRMD) Awarded Dispensary License in Ohio appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
Tetra Bio-Pharma Inc. (TBPMF) Receives EMA Orphan Drug Designation for a Novel Topical

Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic…

The post Tetra Bio-Pharma Inc. (TBPMF) Receives EMA Orphan Drug Designation for a Novel Topical appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
Top US Marijuana Stocks To Buy Now? 3 Florida Cannabis Companies To Watch
Cannabis Litigation: Perpetuating Testimony

Civil litigation in cannabis, like any other industry, usually proceeds in a predicable order. First, a complaint is filed and served. This kicks off the lawsuit and compels a defendant to file an Answer to avoid a default judgment. Second, the parties conduct written discovery: i.e. gathering relevant documents, identifying potential witnesses, and serving interrogatories and

The post Cannabis Litigation: Perpetuating Testimony appeared first on Harris Bricken Sliwoski LLP.

Read more
MindMed Announces At-The-Market Offering

MindMed announces an at-the-market financing with a prospectus authorizing share sales of up to $100,000,000. Not open to Canadian investors.

Read more
MindMed Reports First Quarter 2022 Financial Results and Business Highlights

MindMed reports results for Q1 2022. Progress on clinical trials. Used $12.9 million cash in previous quarter. Cash balance of $120.5 million as of March 31, 2022.

Read more
Cybin to Participate in NYSE Trading Bell Ceremony on May 18, 2022

Cybin Inc announces that it will take part in the NYSE’s “morning bell” ceremony for the May 18th trading session.

Read more
Awakn Life Sciences Appoints UK Leader in Addictions Psychiatry, Dr. Arun Dhandayudham, as Chief Medical Officer

Awakn Life Sciences announces the appointment of noted expert in addictions psychiatry, Dr. Arun Dhandayudham as its new CMO.

Read more



( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )